HealthCor Management’s Charles River Laboratories CRL Stock Holding History

HealthCor Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-107,800	Closed	-$26.9M	–	89
2020 Q4	$26.9M	Sell	107,800 -134,430	-55%	-$32M	1.04%	34
2020 Q3	$54.9M	Buy	242,230 +141,500	+140%	+$29.4M	2.2%	21
2020 Q2	$17.6M	Sell	100,730 -483,890	-83%	-$77.2M	0.74%	34
2020 Q1	$73.8M	Buy	584,620 +409,620	+234%	+$61.4M	3.15%	12
2019 Q4	$26.7M	Sell	175,000 -190,360	-52%	-$26.4M	0.95%	39
2019 Q3	$48.4M	Buy	365,360 +947	+0.3%	+$127K	1.83%	22
2019 Q2	$51.7M	Buy	+364,413	New	+$49.4M	2.01%	21

Other funds holding CRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

HealthCor Management's CRL Position: Q1 2021 in Review

HealthCor Management sold out of Charles River Laboratories (CRL) in Q1 2021, closing a stake of 107,800 shares — an estimated $26.9M sold.

HealthCor Management first reported a position in CRL in Q2 2019 and held it in 7 quarters. The position peaked at $73.8M in Q1 2020. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2021.

HealthCor Management reported no remaining Charles River Laboratories position as of Q1 2021 after selling out during the quarter.
HealthCor Management sold 107,800 Charles River Laboratories shares in Q1 2021, an estimated $26.9M.
HealthCor Management first reported a position in Charles River Laboratories in Q2 2019 and held it in 7 quarters.
HealthCor Management's Charles River Laboratories position peaked at $73.8M in Q1 2020.
561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2021.

Based on HealthCor Management's 13F filing for Q1 2021, filed 17 May 2021.